COLL— COLLEGIUM PHARMACEUTICAL, INC

MaterialsPharmaceuticals$886M mkt cap

Metric	FY2025	FY2025	FY2025	FY2025
Product revenues, net	$205.4M-1.9%	$209.4M+11.4%	$188.0M+5.8%	$177.8M
Cost of product revenues	—	—	—	—
Cost of product revenues (excluding intangible asset amortization)	$21.6M-12.6%	$24.7M+2.4%	$24.1M-3.3%	$25.0M
Intangible asset amortization	$221.9M+34.2%	$165.3M+13.4%	$145.8M	—
Total cost of product revenues	$77.1M-3.9%	$80.2M+0.7%	$79.6M-1.0%	$80.4M
Gross profit	$128.4M-0.6%	$129.2M+19.2%	$108.4M+11.4%	$97.3M
Selling, general and administrative	$67.6M+0.8%	$67.1M-8.9%	$73.6M-3.6%	$76.4M
Gain on fair value remeasurement of contingent consideration	-$19K+0.0%	-$19K+94.7%	-$358K+54.5%	-$786K
Total operating expenses	$67.6M+0.8%	$67.1M-8.5%	$73.3M-3.1%	$75.6M
Income from operations	$60.8M-2.1%	$62.1M+76.9%	$35.1M+61.9%	$21.7M
Interest expense	-$19.3M+11.4%	-$21.8M-6.4%	-$20.5M+1.6%	-$20.8M
Interest income	$3.6M+14.4%	$3.1M+30.8%	$2.4M+7.1%	$2.2M
Loss on extinguishment of debt	-$16.0M	$0	$0	$0
Income before income taxes	$29.0M-33.2%	$43.4M+155.1%	$17.0M+445.3%	$3.1M
Provision for income taxes	$12.1M+1.2%	$11.9M+136.6%	$5.0M+615.2%	$705K
Net income	$17.0M-46.2%	$31.5M+162.9%	$12.0M+395.8%	$2.4M
Earnings per share - basic (in dollars per share)	$0.54-46.0%	$1.00+163.2%	$0.38+375.0%	$0.08
Weighted-average shares - basic (in shares)	31.65B+0.3%	31.57B-0.8%	31.81B+0.1%	31.79B
Earnings per share - diluted (in dollars per share)	$0.46-45.2%	$0.84+147.1%	$0.34+385.7%	$0.07
Weighted-average shares - diluted (in shares)	40.08B+1.6%	39.44B+0.9%	39.08B+19.0%	32.84B

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 16 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.